glp-1 fda approved for weight loss A big win Wegovy: drug semaglutide first in history to gain approval for reducing heart risks Benefits of Semaglutide GLP-1 Injections

CHA Last Week:11 Record: 36-24 OffRtg: 116.5 (10) DefRtg: 116.3 (22) NetRtg: +0.2 (16) Pace: 99.4 (20) The Lakers had a bizarro week by their standards, losing two close games and winning two blowouts

TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimers disease

Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease

TBK1 (TANK-binding kinase 1)-mediated regulation of autophagy in health and disease